Investigational malaria vaccine gives strong, lasting protection
Having trouble viewing this email? View it as a Web page . You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH). Investigational malaria vaccine gives strong, lasting protection 06/30/2021 11:00 AM EDT Phase 1 trials conducted at NIH Clinical Center. Update Your E-mail Address | Add Subscriptions | Unsubscribe All If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com . For all other inquiries about NIH programs and activities, please contact Ask NIH . Before writing, please view our Frequently Asked Questions page, our Health Information page, or Search our website. This service is provided to you by the National Institutes of Health . NIH…Turning Discovery Into Health ® This email was sent to linus.stotts.epicblog@blogger.com usin...